The WACC of Seres Therapeutics Inc (MCRB) is 9.5%.
| Range | Selected | |
| Cost of equity | 8.10% - 12.50% | 10.30% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 16.10% | 11.55% |
| WACC | 6.8% - 12.2% | 9.5% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.91 | 1.37 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.10% | 12.50% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.72 | 0.72 |
| Cost of debt | 7.00% | 16.10% |
| After-tax WACC | 6.8% | 12.2% |
| Selected WACC | 9.5% | |